Sachs Associates would like to say that we have enjoyed hosting you in-person and virtually, and thank those who participated in our Sachs Spring Life Sciences Week, which incorporated the 1st Annual European Neuroscience Innovation Forum (#Sachs_ENIF) and the 19th Annual European Life Sciences CEO Forum (#Sachs_ELSF). A special thank you goes to the excellent line-up of sponsors, chairs, panellists, an exhibitor, and presenters who made such a broad and interesting programme possible and to those who participated in-person and during the virtual week.
The Life Sciences Week has proven highly successful, with over 500 participants from 27 countries registered and nearly 2300 in-person & online meetings completed.
Publicly available recordings of the sessions and presentations from the event will be uploaded to the SachsTV YouTube channel in April.
We are looking forward to welcoming you again to our future events!
BRONZE SPONSOR:
CONTRIBUTING SPONSORS:
Presenting Companies Included:
Exhibitors Included:
Confirmed Keynote Speakers Included:
Helen Chen
Global Sector Co-Head, Healthcare & Life Sciences | Greater China Managing Partner, L.E.K. Consulting
Patrick Aebischer
President Emeritus, École polytechnique fédérale de Lausanne (EPFL)
Speakers and Chairs Included:
Andreas Wallnoefer
Managing Director, ClavystBio
Butrint Aliu
Associate, Pureos Bioventures
Diana Saraceni
Co-Founder & General Partner, Panakès Partners SGR SpA
Edward van Wezel
Managing Partner, BioGeneration Ventures (BGV)
Elena Startseva
Global Clinical Development Lead, Boehringer Ingelheim International GmbH
Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
Evonne Sepsis
Managing Director, ESC Advisors
Gregory Rall
Deputy Head, Innovation & Technology, InvestHK
Gábor Gyülvészi
Principal/Seed-Stage Investor, Novo Holdings A/S
Khatereh Ahmadi
Venture Partner, XGEN Venture SGR S.p.A.
Melanie de Almeida
Senior Associate, Forbion
Odile Rundquist
Partner, Bioqube Ventures
Rainer Strohmenger
Managing Partner, Wellington Partners
Regina Hodits
Managing Director, Angelini Ventures S.p.A.
Sarah Holland
President of Swiss Healthcare Licensing Group & CBO, CDR-Life AG
Stephanie Léouzon
Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
Victoria English
Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
Andrew Cavey
CEO, ITM Isotope Technologies Munich SE
Anja König
Global Head, Novartis Venture Fund
Ann Beliën
Founder & CEO, Rejuvenate Biomed NV
Apollon Papadimitriou
CEO, iOmx Therapeutics AG
Ari-Pekka Laitsaari
Senior Advisor, European Investment Bank
Björn Cochlovius
CEO, eleva GmbH
Colette Lipp
Senior Director, Global BD Oncology & Immuno-Oncology, Merck KGaA, Darmstadt, Germany
Daniel Marshall
Senior Director, Search & Evaluation, Oncology R&D, BD, AstraZeneca
David Venables
CEO, Laverock Therapeutics Ltd.
David G. Benathan
VP, Head BD&L Transactions Oncology & RLT, Novartis Pharma AG
Dominik Hartl
Chief Medical Officer, Granite Bio
Eric Halioua
Executive Chairman, Ervimmune
Erik van den Berg
CEO, Memo Therapeutics AG
Esther Melo
Senior Director BD&L, F. Hoffmann-La Roche AG
Fabian Buller
CBO, Neurimmune AG
Fabrizio Calisti
Medical Director, Angelini Ventures S.p.A.
Hemant Sabherwal
Head of Corporate Solutions & EMEA Issuer Services, Hong Kong Exchanges and Clearing Limited (HKEX)
Henning Steinhagen
Venture Partner, Epidarex Capital
Jan Poth
Managing Director & CEO, SciRhom GmbH
Jeremy Griggs
Executive Director, Search & Evaluation, GSK
Josua Jordi
Chief Scientific Officer, Tanai Therapeutics
Katharina Kreymborg
SVP, Curie.Bio
Konstantin Petropoulos
CEO, Secarna Pharmaceuticals GmbH & Co. KG
Laura Lane
VP Lilly Ventures - Head of Europe, Eli Lilly and Company
Leila Jaafar-Thiel
Founder & CEO, Nuclidium
Lena Afeyan
Head of UK Science Strategy & Innovation, Flagship Pioneering
Luca Cassetta
Founder & VP Immunology, Macomics Ltd.
Lucy Singah
CFO, Resolution Therapeutics
Madiha Derouazi
CEO, Switchkine SA
Markus Kalousek
Venture Partner, BioGeneration Ventures (BGV)
Markus Werner
Head Search & Evaluation Oncology, Novartis Pharma AG
Michael Wacker
Managing Partner, BioMedVC AG
Michael Bauer
Partner, Novo Holdings A/S
Michael Altorfer
CEO, Swiss Biotech Association
Michio Painter
Head, UMZH Translational Medicine Accelerator
Nigel Sheail
Partner, Versant Ventures
Paul Hermant
Partner, Bird & Bird (Belgium) LLP
Quin Wills
Founder & CEO, Ochre Bio Ltd.
Rainer Strohmenger
Managing Partner, Wellington Partners
Richard Ward
Executive Director, Oncology Search & Evaluation, GSK
Robert Augustin
Director Strategic Partnering Cardiorenalmetabolism, Global BD&L, Boehringer Ingelheim International GmbH
Romana Gugenberger
Chief Medical & Scientific Officer, invIOs GmbH
Steffen-Sebastian Bolz
Chief Scientific Officer, Aphaia Pharma AG
Stella Gu
Managing Director, Tigermed
Stephan Lensky
COO & CBO, EpimAb Biotherapeutics
Tamas Schweighoffer
Co-Founding Partner, Forty51 Ventures AG
Ted Fjällman
CEO, Flerie Invest AB
Thierry Laugel
Managing Partner, Kurma Partners
Victoria Taylor
Principal, Medicxi
Ximing Ding
Principal, Pureos Bioventures